Bladder Cancer - Results from #60

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma. September 9, 2020

[Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial]. September 9, 2020

Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect. September 8, 2020

Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer. September 8, 2020

Comparison of Major Complications at 30 and 90 days Following Radical Cystectomy. September 8, 2020

Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system. September 8, 2020

Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells. September 7, 2020

Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer. September 7, 2020

Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer. September 7, 2020

The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis. September 7, 2020

Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going? September 7, 2020

Monopolar versus bipolar transurethral resection of bladder tumors: An updated systematic review and meta-analysis of existing studies. September 4, 2020

Immunotherapy for urothelial carcinoma: Metastatic disease and beyond. September 4, 2020

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Seconda September 4, 2020

IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity. September 4, 2020

Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients. September 4, 2020

Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution. September 3, 2020

Genomic predictors of good outcome, recurrence or progression in High grade T1 non-muscle invasive bladder cancer. September 3, 2020

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. September 3, 2020

Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt/IL1β signaling pathway in human bladder cancer. September 3, 2020

Page 4 of 364